| Richard J Conklin, MD | |
|
310 S Penn St, Suite 105, Aberdeen, SD 57401-4553 | |
| (605) 622-8700 | |
| (605) 622-5056 |
| Full Name | Richard J Conklin |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 41 Years |
| Location | 310 S Penn St, Aberdeen, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851394662 | NPI | - | NPPES |
| 6002122 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 2823 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera St Lukes | Aberdeen, SD | Hospital |
| Bowdle Hospital - Cah | Bowdle, SD | Hospital |
| Community Memorial Hospital | Redfield, SD | Hospital |
| Milbank Area Hospital/avera Health | Milbank, SD | Hospital |
| Mobridge Regional Hospital - Cah | Mobridge, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera Mckennan | 0345157103 | 848 |
| Conklin Clinics Prof Llc | 8325391345 | 6 |
News Archive
In today's ageing population, resulting in a rising prevalence of chronic diseases such as neurodegeneration, the need for simple, non-invasive methods to diagnose or screen for important medical conditions becomes more and more relevant. Objective and cost-effective approaches capable of diagnosing early-stage disease in point-of-care clinical settings are necessary to facilitate the personalising of therapies to prevent or slow down pathology development.
Oncothyreon Inc., announced it has entered into a securities purchase agreement in connection with a private placement. Upon the closing of the private placement, Oncothyreon will receive gross proceeds of approximately $14.9 million resulting from the sale of approximately 4.24 million units at a purchase price of $3.50 per unit.
Abbott announced today it has obtained CE Marking (Conformite Europeene) in the European Union to market its rapid, high-throughput PLEX-ID instrument, along with three assays for use on the system: PLEX-ID Viral IC Spectrum, PLEX-ID BAC Spectrum BC and PLEX-ID Flu.
"The number of new HIV cases in Saudi Arabia declined by 9 percent to 1,121 in 2010 from the previous year, the official Saudi Press Agency said, citing a Health Ministry official," Bloomberg reports.
› Verified 6 days ago
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
In today's ageing population, resulting in a rising prevalence of chronic diseases such as neurodegeneration, the need for simple, non-invasive methods to diagnose or screen for important medical conditions becomes more and more relevant. Objective and cost-effective approaches capable of diagnosing early-stage disease in point-of-care clinical settings are necessary to facilitate the personalising of therapies to prevent or slow down pathology development.
Oncothyreon Inc., announced it has entered into a securities purchase agreement in connection with a private placement. Upon the closing of the private placement, Oncothyreon will receive gross proceeds of approximately $14.9 million resulting from the sale of approximately 4.24 million units at a purchase price of $3.50 per unit.
Abbott announced today it has obtained CE Marking (Conformite Europeene) in the European Union to market its rapid, high-throughput PLEX-ID instrument, along with three assays for use on the system: PLEX-ID Viral IC Spectrum, PLEX-ID BAC Spectrum BC and PLEX-ID Flu.
"The number of new HIV cases in Saudi Arabia declined by 9 percent to 1,121 in 2010 from the previous year, the official Saudi Press Agency said, citing a Health Ministry official," Bloomberg reports.
› Verified 6 days ago
| Entity Name | Avera St Lukes |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215100813 PECOS PAC ID: 6406764927 Enrollment ID: O20040120000912 |
News Archive
In today's ageing population, resulting in a rising prevalence of chronic diseases such as neurodegeneration, the need for simple, non-invasive methods to diagnose or screen for important medical conditions becomes more and more relevant. Objective and cost-effective approaches capable of diagnosing early-stage disease in point-of-care clinical settings are necessary to facilitate the personalising of therapies to prevent or slow down pathology development.
Oncothyreon Inc., announced it has entered into a securities purchase agreement in connection with a private placement. Upon the closing of the private placement, Oncothyreon will receive gross proceeds of approximately $14.9 million resulting from the sale of approximately 4.24 million units at a purchase price of $3.50 per unit.
Abbott announced today it has obtained CE Marking (Conformite Europeene) in the European Union to market its rapid, high-throughput PLEX-ID instrument, along with three assays for use on the system: PLEX-ID Viral IC Spectrum, PLEX-ID BAC Spectrum BC and PLEX-ID Flu.
"The number of new HIV cases in Saudi Arabia declined by 9 percent to 1,121 in 2010 from the previous year, the official Saudi Press Agency said, citing a Health Ministry official," Bloomberg reports.
› Verified 6 days ago
| Entity Name | Conklin Clinics Prof Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457831497 PECOS PAC ID: 8325391345 Enrollment ID: O20181022001140 |
News Archive
In today's ageing population, resulting in a rising prevalence of chronic diseases such as neurodegeneration, the need for simple, non-invasive methods to diagnose or screen for important medical conditions becomes more and more relevant. Objective and cost-effective approaches capable of diagnosing early-stage disease in point-of-care clinical settings are necessary to facilitate the personalising of therapies to prevent or slow down pathology development.
Oncothyreon Inc., announced it has entered into a securities purchase agreement in connection with a private placement. Upon the closing of the private placement, Oncothyreon will receive gross proceeds of approximately $14.9 million resulting from the sale of approximately 4.24 million units at a purchase price of $3.50 per unit.
Abbott announced today it has obtained CE Marking (Conformite Europeene) in the European Union to market its rapid, high-throughput PLEX-ID instrument, along with three assays for use on the system: PLEX-ID Viral IC Spectrum, PLEX-ID BAC Spectrum BC and PLEX-ID Flu.
"The number of new HIV cases in Saudi Arabia declined by 9 percent to 1,121 in 2010 from the previous year, the official Saudi Press Agency said, citing a Health Ministry official," Bloomberg reports.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard J Conklin, MD Po Box 1460, Aberdeen, SD 57402-1460 Ph: (605) 622-5613 | Richard J Conklin, MD 310 S Penn St, Suite 105, Aberdeen, SD 57401-4553 Ph: (605) 622-8700 |
News Archive
In today's ageing population, resulting in a rising prevalence of chronic diseases such as neurodegeneration, the need for simple, non-invasive methods to diagnose or screen for important medical conditions becomes more and more relevant. Objective and cost-effective approaches capable of diagnosing early-stage disease in point-of-care clinical settings are necessary to facilitate the personalising of therapies to prevent or slow down pathology development.
Oncothyreon Inc., announced it has entered into a securities purchase agreement in connection with a private placement. Upon the closing of the private placement, Oncothyreon will receive gross proceeds of approximately $14.9 million resulting from the sale of approximately 4.24 million units at a purchase price of $3.50 per unit.
Abbott announced today it has obtained CE Marking (Conformite Europeene) in the European Union to market its rapid, high-throughput PLEX-ID instrument, along with three assays for use on the system: PLEX-ID Viral IC Spectrum, PLEX-ID BAC Spectrum BC and PLEX-ID Flu.
"The number of new HIV cases in Saudi Arabia declined by 9 percent to 1,121 in 2010 from the previous year, the official Saudi Press Agency said, citing a Health Ministry official," Bloomberg reports.
› Verified 6 days ago
Arlin Monroe Myrmoe, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 815 1st Ave Se, Suite E104, Aberdeen, SD 57401 Phone: 605-622-5458 Fax: 605-622-5473 | |
Dr. John Robert Fritz, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1228 18th Ave Ne, Aberdeen, SD 57401 Phone: 605-229-5323 | |
Dr. Racheal Tushabe, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 815 1st Ave Se Ste 104, Aberdeen, SD 57401 Phone: 605-622-5458 Fax: 605-622-5473 | |
Joan Harriott, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3015 3rd Ave Se, Aberdeen, SD 57401 Phone: 605-725-1700 Fax: 605-725-1761 | |
Ronald Douglas Rovang, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 815 1st Ave Se, Suite 104, Aberdeen, SD 57401 Phone: 605-622-5458 Fax: 605-622-5473 | |
Timothy Roy Waterman, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 815 1st Ave Se, Suite 104, Aberdeen, SD 57401 Phone: 605-622-5458 Fax: 605-622-5473 | |
Olawunmi Aabiodun Lawal, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 815 1st Ave Se, Suite 104, Aberdeen, SD 57401 Phone: 605-622-5458 Fax: 605-622-5473 |